Robert C. Bollinger, MD, MPH

CRS:

BJMC

Role:

Investigators

Position:

Professor of Medicine Director, CCGHE Associate Director, Center for Global Health

Email:

rcb@jhmi.edu

Robert C. Bollinger is a Professor of Infectious Diseases at the Johns Hopkins University (JHU) School of Medicine, with joint appointments in International Health at the Johns Hopkins (JH) Bloomberg School of Public Health and in Community Public Health at the JH School of Nursing.  He is the founding Director of the JH Center for Clinical Global Health Education (CCGHE) and the Associate Director for Medicine of the JH Center for Global Health, which coordinates all JHU global health activities.  He also directs the JHU Fogarty India Program, which provides training to Indian scientists, and the Global Health Course for JH medical students, which uses videoconference technology to link medical students and faculty around the globe. 
 
Dr. Bollinger has more than 30 years of experience in international public health, clinical research, and education in a broad range of global health priorities including HIV/AIDS, malaria, tuberculosis, leprosy, and emerging infections.  He has published more than 140 peer-reviewed research publications and 15 book chapters, including the first and largest studies of risk factors for HIV transmission in India, the cloning and sequencing of the first HIV viruses from India, the only studies characterizing the primary immune response to HIV in India, and the demonstration of increased risk of HIV acquisition with recent HSV infection and lack of circumcision. In addition, his commitment to clinician education has been honored with the Johns Hopkins Department of Medicine David M. Levine Excellence in Mentoring Award. Now working with partners in more than 20 countries, Dr. Bollinger and the CCGHE faculty are pioneers and global leaders in the development and use of distance learning and their award-winning mobile Health platform (emocha®) in resource-limited settings (http://emocha.org/). An esteemed global health expert, Dr. Bollinger has contributed to public health training programs, expert committees, and consultations in over 15 countries. He has also been a member of the US Presidential Advisory Council for HIV/AIDS (PACHA), where he served as a member of the PACHA International Sub-committee.  
 
Dr. Bollinger's research interests include identification of biological and behavioral risk factors for HIV transmission; characterization of the clinical progression and treatment of HIV and related infections; and implementation science research projects to optimize health care capacity and care delivery in resource-limited settings through task-shifting, clinical education, distance learning and mobile Health. Dr. Bollinger is actively engaged in collaborative research projects in Colombia, Uganda, and the US and his engagement in India has spanned more than three decades.  In 1992, he initiated an ongoing, NIH-funded Indo-US HIV research program in Pune involving the National AIDS Research Institute/ICMR and the BJ Medical College.  He has also been the Principal Investigator for many NIH-supported studies and clinical trials in Pune, including the SWEN study, which changed World Health Organization (WHO) guidelines. Under Dr. Bollinger’s leadership, the Hopkins Fogarty International Program has provided short-term and degree training to more than 100 visiting scientists at JHU and in-country training to more than 2000 Indian scientists since 1992 (see information about 2013 Training Award).  Under his directorship, ongoing CCGHE programs were initiated in India and are expanding. Recently, Dr. Bollinger was selected to direct the newly formed IMEC-JHU Partnership to advance applications in health care. The collaboration will combine JH clinical and research expertise with IMEC nanoelectronic capabilities (read more).

Dr. Bollinger received an undergraduate degree from Haverford College, a Doctor of Medicine from Dartmouth Medical School, and a Masters in Public Health from JH Bloomberg School of Public Health. He completed his Internal Medicine training at the University of Maryland Medical Systems followed by a post-doctoral fellowship in Infectious Diseases at JHU School of Medicine.  Dr. Bollinger is Board Certified in Internal Medicine and Infectious Diseases by the American Board of Internal Medicine.

.

.

Categories

Leadership Committees
CRS
Roles

Clinical Trials

A5324: A Randomized, Double-Blinded, Placebo-Controlled...

ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...

Read More

NWCS 445: Novel Biomarkers to Shorten TB Treatment

Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...

Read More

A5320: Viral Hepatitis C Infection Long-term Cohort Study...

A5320/V-HICS is an observational, prospective, long-term follow-up study in hepatitis C virus (HCV) monoinfected and HCV/HIV-1...

Read More

P1077BF: Breastfeeding Version of the PROMISE Study...

1077BF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...

Read More

A5274: REMEMBER, Reducing Early Mortality and Early...

This study is being done in people who are starting HIV treatment and who live in areas where the TB infection rate is high. The...

Read More